The drug rituximab, when added to chemotherapy, boosts survival rates in people with diffuse B-cell lymphoma, a kind of cancer.
New treatment increases survival rates in cancer patients.
Cedex France Oliver W. Press University of Washington School of Medicine Box 356043 Seattle, WA 98195 From Science News , Vol. All rights reserved. Subscribe to Science News . Copyright Clearance Center Browse a Science News photo collection. Subscribe to Science News in spoken-word format.